Comparison of the effects of once-monthly versus once-daily risedronate in postmenopausal osteoporosis: A phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study

Autor: Ste-Marie, Louis-Georges, Brown, Jacques P., Beary, John F., Matzkin, Ellen, Darbie, Lynn M., Burgio, David E., Racewicz, Artur J.
Zdroj: In Clinical Therapeutics 2009 31(2):272-285
Databáze: ScienceDirect
Externí odkaz: